NanoRibo Biotechnology

Company Deals

Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform

Fineline Cube Jan 29, 2026

Chengdu Kanghua Biological Products Co., Ltd. (SHE: 300841) announced a plan to increase capital investment...

Company Drug

United Labs TUL108 Gets FDA Nod for Antibiotic Resistance Trial

Company Deals

Fosun Pharma Licenses HPV DNA Drug VGX-3100 from ApolloBio for Greater China

Company Deals

Kanghua to Acquire NanoRibo in Phased Deal for mRNA Platform

Company Deals

Lisata Reclaims Certepetide China Rights Amid Kuva Acquisition, CVR Milestone Triggered